Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
120mg/0.5ml glatiramer acetate[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
240 mg glatiramer acetate[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[2] 2, 13 💬
340 mg Glatiramer acetato[1] Glatiramer (Teva-glatiramer Acetate)---[1] 13 💬
4Cyclophosphamide/Glatiramer acetate[3] Acetate,
Cyclophosphamide,
Glatiramer (Teva-glatiramer Acetate)		[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 13 💬
5Experimental Glatiramer Acetate[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
6Glatiramer[1] Glatiramer (Teva-glatiramer Acetate)---[4] 2, 13, 96, 156 💬
7GLATIRAMER ACETATE[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[3] 13, 96, 156 💬
8Glatiramer Acetate (Copaxone®)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[2] 13, 156 💬
9Glatiramer Acetate (DB)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
10Glatiramer Acetate (GA)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
11Glatiramer Acetate (GA) 40 mg[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
12Glatiramer Acetate (GTR)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
13Glatiramer Acetate (OL)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
14Glatiramer acetate 150mg enteric coated tablets[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
15Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
16Glatiramer acetate 20 mg[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
17Glatiramer acetate 20 mg, with mitoxantrone[3] Acetate,
Glatiramer (Teva-glatiramer Acetate),
Mitoxantrone		[1] Mitoxantrone 💬 [2] TOP2A,
TOP2B 💬 		[1] Platinum drug resistance 💬[1] 13 💬
18Glatiramer Acetate 20 mg/0.5 mL[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
19Glatiramer acetate 40 mg[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
20Glatiramer Acetate [GA][2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
21Glatiramer acetate injection with oral cetirizine hydrochloride[3] Acetate,
Cetirizine,
Glatiramer (Teva-glatiramer Acetate)		[1] Cetirizine 💬 [1] HRH1 💬 [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 13 💬
22Glatiramer acetate with minocycline[3] Acetate,
Glatiramer (Teva-glatiramer Acetate),
Minocycline		[1] Minocycline 💬 --[1] 13 💬
23Glatiramer acetate, (Copaxone®)[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
24Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b[2] Acetate,
Glatiramer (Teva-glatiramer Acetate)		---[1] 13 💬
25Glatiramer Acetate, N-Acetylcysteine[3] Acetate,
Acetylcysteine,
Glatiramer (Teva-glatiramer Acetate)		[1] Acetylcysteine 💬 --[1] 13 💬
26GLATIRAMER ACETATO[1] Glatiramer (Teva-glatiramer Acetate)---[1] 13 💬
27GLATIRAMERO ACETATO----[1] 13 💬
28Human interferon beta-1a and glatiramer acetate[4] Acetate,
Glatiramer (Teva-glatiramer Acetate),
Human interferon beta,
Interferon beta-1a		[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
29Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab[12] Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer (Teva-glatiramer Acetate),
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		[10] Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬 		[7] CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬 		[30] Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬[1] 13 💬